Search results for "Glioblast"

showing 10 items of 141 documents

Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae

2003

Vasogenic edema is one of the most serious clinical problems in brain tumors and tightly connected to water shifts between the different fluid compartments in the brain. Aquaporin water channels have been recognized to have an important impact on the development of edematous swelling in the brain. Astrocytes, which are believed to induce or at least maintain the blood-brain barrier in the brain capillary endothelial cells, express the aquaporin isoform AQP4. Normally, AQP4 is highly concentrated in the glial membrane where astrocytes contact mesenchymal space, such as perivascular or brain superficial regions. Parenchymal membranes do not show any immunocytochemical AQP4-specific signal. We…

Models NeurologicalSynucleinsAquaporinNerve Tissue ProteinsBiologyAquaporinsBlood–brain barrierBasement MembranePathology and Forensic MedicineCellular and Molecular NeuroscienceGliomaUtrophinmedicineExtracellularAnimalsHumansAgrinDystroglycansAquaporin 4Membrane GlycoproteinsAgrinBrain NeoplasmsEndothelial Cellsmedicine.diseaseImmunohistochemistryRatsCell biologyCytoskeletal Proteinsmedicine.anatomical_structureAquaporin 4Immunologysense organsNeurology (clinical)GlioblastomaAstrocyteActa Neuropathologica
researchProduct

The triad hsp60-mirnas-extracellular vesicles in brain tumors: Assessing its components for understanding tumorigenesis and monitoring patients

2021

Brain tumors have a poor prognosis and progress must be made for developing efficacious treatments, but for this to occur their biology and interaction with the host must be elucidated beyond current knowledge. What has been learned from other tumors may be applied to study brain tumors, for example, the role of Hsp60, miRNAs, and extracellular vesicles (EVs) in the mechanisms of cell proliferation and dissemination, and resistance to immune attack and anticancer drugs. It has been established that Hsp60 increases in cancer cells, in which it occurs not only in the mitochondria but also in the cytosol and plasma-cell membrane and it is released in EVs into the extracellular space and in cir…

Molecular chaperonesCellBrain tumorBiologymedicine.disease_causelcsh:Technologylcsh:Chemistry03 medical and health sciences0302 clinical medicineImmune systemHigh-grade gliomaExtracellularmedicineGeneral Materials Sciencelcsh:QH301-705.5Instrumentation030304 developmental biologyFluid Flow and Transfer Processes0303 health sciencesLiquid biopsylcsh:TProcess Chemistry and TechnologyGeneral EngineeringCancerTumor biomarkersChaperonopathiesExtracellular vesiclesmedicine.diseaseHsp60lcsh:QC1-999Computer Science ApplicationsCrosstalk (biology)medicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040030220 oncology & carcinogenesisCancer cellCancer researchChaperone systemMiRNAslcsh:Engineering (General). Civil engineering (General)CarcinogenesisGlioblastomaMeningiomalcsh:Physics
researchProduct

Impact of carbon ion irradiation on epidermal growth factor receptor signaling and glioma cell migration in comparison to conventional photon irradia…

2013

PURPOSE: Radiotherapy of malignant gliomas may be limited by an interference of radiation with the migratory potential of tumor cells. Therefore, the influence of conventional photon and modern carbon ion ((12)C) irradiation on glioblastoma cell migration and on epidermal growth factor receptor-related (EGFR) signaling was investigated in vitro. MATERIALS AND METHods: EGFR overexpressing glioblastoma cell lines U87 EGFR++ and LN229 EGFR++ were irradiated with 0, 2 or 6 Gy photons or (12)C heavy ions. Migration was analyzed 24 h after treatment in a standardized Boyden Chamber assay. At different time points EGFR, protein kinase B (PKB/AKT) and extracellular signal-related kinases (ERK1/2) w…

MotilityRadiation DosageCell MovementEpidermal growth factorCell Line TumorGliomamedicineHumansHeavy IonsRadiology Nuclear Medicine and imagingEpidermal growth factor receptorProtein kinase BPhotonsRadiological and Ultrasound TechnologybiologyChemistryKinaseDose-Response Relationship Radiationmedicine.diseaseCarbonErbB ReceptorsCell cultureImmunologyCancer researchbiology.proteinPhosphorylationGlioblastomaSignal TransductionInternational Journal of Radiation Biology
researchProduct

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme

2008

Abstract Purpose: Cancer stem cells (CSC) are thought to represent the population of tumorigenic cells responsible for tumor development. The stem cell antigen CD133 identifies such a tumorigenic population in a subset of glioblastoma patients. We conducted a prospective study to explore the prognostic potential of CSC analysis in glioblastoma patients. Experimental Design: We investigated the relationship between the in vitro growth potential of glioblastoma CSCs and patient death or disease progression in tumors of 44 consecutive glioblastoma patients treated with complete or partial tumorectomy followed by radiotherapy combined with temozolomide treatment. Moreover, we evaluated by immun…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyPathologyAC133 Antigen; Adult; Aged; Antigens CD; Brain Neoplasms; Female; Glioblastoma; Glycoproteins; Humans; Ki-67 Antigen; Male; Middle Aged; Multivariate Analysis; Neoplastic Stem Cells; Peptides; Prospective Studiesmedicine.medical_treatmentPopulationAntigens CDCancer stem cellInternal medicinemedicineHumansAC133 AntigenProspective StudiesAntigensProspective cohort studyeducationAgedGlycoproteinseducation.field_of_studyTemozolomideSettore MED/08 - ANATOMIA PATOLOGICAbusiness.industryBrain NeoplasmsHazard ratioMiddle AgedGliobastoma MultiformeCDRadiation therapyKi-67 AntigenOncologyMultivariate AnalysisNeoplastic Stem CellsImmunohistochemistryFemaleStem cellbusinessGlioblastomaPeptidesmedicine.drug
researchProduct

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PAT…

2017

There is an urgent need for more effective therapies in glioblastoma (GBM). Data from the single arm UKT-03 trial (Glas et al., J Clin Oncol 27, 1257, 2009) suggested that combined lomustine/temozolomide (CCNU/TMZ) therapy might have superior activity in MGMT-methylated GBM. The phase III CeTeG/NOA-09 trial was set up to test this hypothesis in a randomized setting. Patients with MGMT-methylated GBM were randomized (1:1) for standard therapy with daily TMZ (75 mg/m2) during local radiotherapy (RT, 30 x 2 Gy) followed by 6 courses of TMZ (150–200 mg/m2/day for 5 days q4w) or experimental therapy with CCNU/TMZ in addition to local RT. Six 6-week courses of CCNU/TMZ (CCNU 100 mg/m2 d1, TMZ 100…

OncologyCancer Researchmedicine.medical_specialtyTemozolomideCombination therapybusiness.industrymedicine.medical_treatmentO-6-methylguanine-DNA methyltransferaseLomustinemedicine.diseaseRadiation therapyAbstracts03 medical and health sciences0302 clinical medicineText miningOncology030220 oncology & carcinogenesisInternal medicinemedicineCombined Modality TherapyNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugGlioblastomaNeuro-Oncology
researchProduct

Study of the activation of TLR receptors in neurospheres from glioblastoma cells in vitro

2018

Oncologybusiness.industryNeurosphereCancer researchMedicineHematologybusinessmedicine.diseaseReceptorIn vitroGlioblastomaAnnals of Oncology
researchProduct

With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas

2018

High-grade gliomas (HGGs) are the most frequent primary malignant brain tumors in adults, which lead to death within two years of diagnosis. Maximal safe resection of malignant gliomas as the first step of multimodal therapy is an accepted goal in malignant glioma surgery. Gross total resection has an important role in improving overall survival (OS) and progression-free survival (PFS), but identification of tumor borders is particularly difficult in HGGS. For this reason, imaging adjuncts, such as 5-aminolevulinic acid (5-ALA) or fluorescein sodium (FS) have been proposed as superior strategies for better defining the limits of surgical resection for HGG. 5-aminolevulinic acid (5-ALA) is i…

Oncologymedicine.medical_specialtyReviewlcsh:RC321-571Resection03 medical and health scienceschemistry.chemical_compoundHigh-grade glioma0302 clinical medicineGliomaInternal medicineYELLOW 560 filterMedicinefluorescein sodiumastrocytomalcsh:Neurosciences. Biological psychiatry. NeuropsychiatryProtoporphyrin IXSettore MED/27 - Neurochirurgiabusiness.industryGeneral NeuroscienceglioblastomaAstrocytomaMultimodal therapymedicine.diseaseFluorescenceextent of resectionchemistry5-aminolevulinic acid030220 oncology & carcinogenesisPrimary Malignant Brain TumorsSodium fluoresceinbusinesshigh-grade gliomas030217 neurology & neurosurgeryBrain Sciences
researchProduct

Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study

2019

Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the tumor and edema can be distinguished: high angiogenic tumor (HAT), low angiogenic tumor (LAT), infiltrated peripheral edema (IPE), and vasogenic peripheral edema (VPE). Purpose To validate the association between hemodynamic markers from vascular habitats and overall survival (OS) in glioblastoma patients, considering the intercenter variability of acquisition protocols. Study Type Multicenter retrospective study. Population In all, 184 glioblastoma patients from seven European centers participating in the NCT03439332 c…

Oncologymedicine.medical_specialtyVascularityContrast MediaPerfusion DSC030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalHumansRadiology Nuclear Medicine and imagingOverall survivalRetrospective StudiesBrain Neoplasmsbusiness.industryPrognosismedicine.diseaseMagnetic Resonance ImagingMulticenter studyPeer reviewddc:616.8Multicenter studyglioblastoma multicenter study overall survival perfusion DSC vascularitybusinessGlioblastomaGlioblastoma
researchProduct

The Role of Medicinal Mushrooms in Brain Cancer Therapies: Review.

2021

Medicinal mushrooms are considered an unlimited source of polysaccharides (mainly β-glucans) and polysaccharide-protein complexes and possess various immunological and anticancer properties. In addition, their use in integrative medicine leads to a clear reduction of side effects in patients undergoing chemotherapy or radiotherapy. The literature reports a number of beneficial effects of using mushrooms as health supplements in patients affected by high-grade glioma. The effects of medicinal mushrooms on side effects in patients with brain cancer and a case study report are also described in this review.

Oncologymedicine.medical_specialtymedicine.medical_treatmentMEDLINEApplied Microbiology and BiotechnologyBrain cancerStudy reportPolysaccharidesInternal medicineGliomaDrug DiscoverymedicineHumansIn patientintegrative therapies brain cancer glioblastoma medicinal mushrooms mycotherapeutic supportPharmacologyChemotherapybusiness.industryBrain Neoplasmsmedicine.diseaseRadiation therapySettore BIO/03 - Botanica Ambientale E ApplicataDietary SupplementsIntegrative medicinebusinessAgaricalesInternational journal of medicinal mushrooms
researchProduct

Patrones de amplificación de EGFR en el glioblastoma, e identificación de biomarcadores implicados en sus principales vías de señalización

2022

En España, más de 4000 personas serán diagnosticadas anualmente con un tumor maligno cerebral que en su mayoría recaerán en el grupo que se denomina Gliomas Malignos. La mayoría son glioblastomas (grado IV) (GB), siendo estos el tipo más agresivo. Se espera que la supervivencia media para los pacientes tratados con protocolo estándar sea de alrededor de 15 meses. La esperanza de vida tan reducida se debe a que son tumores muy proliferativos y heterogéneos. Esto subraya la necesidad de buscar alternativas para mejorar su manejo. Los estudios de esta tesis se centran en caracterizar biomarcadores y alteraciones genéticas en los diferentes estatus de presentación del EGFR que permitan abordar …

PTENbiomarcadoressupervivenciaEGFRARF1metilación ADNUNESCO::CIENCIAS MÉDICASglioblastomaMVPADD3:CIENCIAS MÉDICAS [UNESCO]
researchProduct